Evidence map›Paper›PMID 36040170›Full record

ArticleAntimicrobial agents and chemotherapy2022

Molecular and Kinetic Characterization of MOX-9, a Plasmid-Mediated Enzyme Representative of a Novel Sublineage of MOX-Type Class C β-Lactamases.

Alessandra Piccirilli, Alberto Antonelli, Marco Maria D'Andrea, Sabrina Cherubini, Mariagrazia Perilli, Gian Maria Rossolini

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Whole genome sequence analysis ofFrontiers in microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Alessandra PiccirilliDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.ORCID 0000-0001-7560-5221
Alberto AntonelliDepartment of Experimental and Clinical Medicine, University of Florencegrid.8404.8, Florence, Italy.ORCID 0000-0003-0295-6877
Marco Maria D'AndreaDepartment of Biology, University of Rome Tor Vergata, Rome, Italy.
Sabrina CherubiniDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Mariagrazia PerilliDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.ORCID 0000-0001-7370-1455
Gian Maria RossoliniDepartment of Experimental and Clinical Medicine, University of Florencegrid.8404.8, Florence, Italy.ORCID 0000-0002-9386-0434
University of L'Aquila · ITUniversity of Florence · ITUniversity of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The MOX lineage of β-lactamases includes a group of molecular class C enzymes (AmpCs) encoded by genes mobilized from the chromosomes of

Indexed as

beta-LactamasesSulbactamBacterial ProteinsCephalosporinsClavulanic AcidKineticsPlasmidsTazobactamBacterial Proteinsbeta-LactamasesCephalosporinsClavulanic AcidSulbactamTazobactamenzyme kineticssMOXβ-lactamases

Identifiers

PMID36040170
PMCPMC9487596
OpenAlexW4293567482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.